Manufacturers Life Insurance Company, The Alx Oncology Holdings Inc Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.84 - $17.56 $271,308 - $815,784	-46,457 Reduced 77.28%	13,662 $82,000
Q1 2024 May 14, 2024	BUY	$10.95 - $16.79 $132,057 - $202,487	12,060 Added 25.09%	60,119 $670,000
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $231,163 - $739,147	48,059 New	48,059 $715,000
Q1 2022 May 20, 2022	SELL	$13.65 - $22.06 $134,548 - $217,445	-9,857 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$21.49 - $74.4 $11,153 - $38,613	519 Added 5.56%	9,857 $212,000
Q3 2021 Nov 12, 2021	SELL	$52.51 - $80.91 $42,900 - $66,103	-817 Reduced 8.05%	9,338 $690,000
Q2 2021 Aug 12, 2021	BUY	$52.2 - $75.23 $16,651 - $23,998	319 Added 3.24%	10,155 $555,000
Q1 2021 May 03, 2021	BUY	$62.84 - $87.68 $251,045 - $350,281	3,995 Added 68.4%	9,836 $725,000
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $199,236 - $655,710	5,841 New	5,841 $503,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.